相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。HDL structure and function is profoundly affected when stored frozen in the absence of cryoprotectants
Michael Holzer et al.
JOURNAL OF LIPID RESEARCH (2017)
Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients
Mihaela G. Carnuta et al.
SCIENTIFIC REPORTS (2017)
Dysfunctional HDL and atherosclerotic cardiovascular disease
Robert S. Rosenson et al.
NATURE REVIEWS CARDIOLOGY (2016)
HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels
Wijtske Annema et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
Danish Saleheen et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk
Anouar Hafiane et al.
BBA CLINICAL (2015)
Lipoproteins as Biomarkers and Therapeutic Targets in the Setting of Acute Coronary Syndrome
Robert S. Rosenson et al.
CIRCULATION RESEARCH (2014)
An abundant dysfunctional apolipoprotein A1 in human atheroma
Ying Huang et al.
NATURE MEDICINE (2014)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
Edward A. Fisher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Cohort Profile: The Corogene study
Satu Vaara et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Benjamin F. Voight et al.
LANCET (2012)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events
Robert S. Rosenson et al.
CLINICAL CHEMISTRY (2011)
Synthetic single-framework antibody library integrated with rapid affinity maturation by VL shuffling
E. -C. Brockmann et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2011)
Dysfunctional HDL as a Diagnostic and Therapeutic Target
Jonathan D. Smith
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins
Sanjay Patel et al.
ATHEROSCLEROSIS (2009)
The metabolism and anti-atherogenic properties of HDL
Kerry-Anne Rye et al.
JOURNAL OF LIPID RESEARCH (2009)
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
Matthias Briel et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Philip Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men
Gosta Florvall et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2006)
Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis
Anatol Kontush et al.
PHARMACOLOGICAL REVIEWS (2006)
Improved early risk stratification and diagnosis of myocardial infarction, using a novel troponin I assay concept
T Ilva et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component
S Eriksson et al.
CLINICAL CHEMISTRY (2003)
Hugh Sinclair Lecture: The regulation and remodelling of HDL by plasma factors
PJ Barter
ATHEROSCLEROSIS SUPPLEMENTS (2002)
Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease -: The PRIME Study
G Luc et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study
G Walldius et al.
LANCET (2001)